P
Paul J. van Diest
Researcher at Utrecht University
Publications - 514
Citations - 22750
Paul J. van Diest is an academic researcher from Utrecht University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 70, co-authored 459 publications receiving 18892 citations. Previous affiliations of Paul J. van Diest include University Medical Center Utrecht & VU University Medical Center.
Papers
More filters
Journal ArticleDOI
Chromosome 17 polysomy without HER2 amplification does not predict response to lapatinib in metastatic breast cancer--letter.
TL;DR: The authors report that in a group of 405 HER2 FISH-negative patients, patients with chromosome 17 polysomy without HER2 amplification and prediction of response of metastatic breast cancer patients to lapatinib are cured.
Journal ArticleDOI
Ovarian carcinogenesis, an alternative theory.
Journal ArticleDOI
Validation of a whole-slide image-based teleconsultation network
Alexi Baidoshvili,Nikolas Stathonikos,Gerard Freling,Jos Bart,Nils A. 't Hart,Jeroen van der Laak,Jan J. Doff,Bert van der Vegt,Philip M. Kluin,Paul J. van Diest +9 more
TL;DR: The aim of this study was to validate a whole‐slide image‐based teleconsultation network between three independent laboratories.
Journal ArticleDOI
EGFR Expression Predicts BRCA1 Status in Patients with Breast Cancer
TL;DR: To the Editor: In their article, Lakhani et al. report on the value of basal phenotype markers for the prediction of BRCA1 status, one of the useful features pointing to “BRCA 1-ness” appeared to be high expression of the epidermal growth factor receptor (EGFR).
Journal ArticleDOI
Mutational analysis using Sanger and next generation sequencing in sporadic spindle cell hemangiomas : a study of 19 cases
Roel W. Ten Broek,Elise M. Bekers,Wendy W.J. de Leng,Eric Strengman,Bastiaan B J Tops,Heinz Kutzner,Jan Willem Leeuwis,Joost van Gorp,David Creytens,Thomas Mentzel,Paul J. van Diest,Astrid Eijkelenboom,Uta Flucke,Uta Flucke +13 more
TL;DR: Given that IDH1/2 mutations were absent in 161 other vascular lesions tested by smMIP/NGS, the mutation can be considered as highly specific for SCH.